The largest database of trusted experimental protocols

C3h mice

Manufactured by Jackson ImmunoResearch
Sourced in United States

C3H mice are a common laboratory mouse strain. They are used in various research applications due to their well-characterized genetic and physiological characteristics.

Automatically generated - may contain errors

9 protocols using c3h mice

1

MMTV Positive Breast Cancer Specimens

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fifty-five breast cancer specimens from Australian women were included in this study. All the specimens were from the archives of an Australian pathology service (Douglass Hanly Moir—Pathology) and had been formalin fixed and paraffin mounted. A study based on PCR analyses of MMTV in these specimens has previously been published (39 (link)). Additional specimens were invasive breast cancers from women who had previously had benign breast conditions and who several years later developed breast cancer. These specimens all differ from those used in our previous publications (31 (link), 42 (link)).
Ten archival MMTV positive mouse mammary tumors in C3H mice were from the Jackson laboratories (ME, USA).
+ Open protocol
+ Expand
2

Generation of Anti-Arp Antibodies in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Anti-Arp antibodies were raised in C3H mice (Jackson Laboratory, Bar Harbor, ME) by inoculating the mice with purified recombinant Arp as a water-in-oil emulsion formulation. A 0.5 mL volume of aqueous Arp antigen was emulsified in 0.5 mL of Titermax Gold (Sigma Aldrich, St. Louis, MO) adjuvant using a two-syringe, 3-way stopcock method. Each mouse was inoculated subcutaneously with 100 μl (36 μg protein) of the emulsion in four divided doses at four different sites. A booster dose of Arp antigen (total 12 μg) was administered in exactly in the same manner 28 days after the initial inoculation. Blood was collected (through cardiac puncture) after 2 weeks of booster dose and centrifuged at 6,000×g for 12 minutes at 4°C to separate serum from blood cellular components. Anti-Arp antibodies were isolated from serum using Melon Gel IgG Purification kit (Thermo Scientific).
+ Open protocol
+ Expand
3

Chagas Disease in Mouse Model

Check if the same lab product or an alternative is used in the 5 most similar protocols
The Brazil strain of T. cruzi was maintained in C3H mice (Jackson Laboratories, Bar Harbor, ME, USA). Male CD-1 mice (Charles River, Wilmington, MA, USA) 8 to 10 weeks old (weighing 25–35 g) were infected intraperitoneally with 5×104 trypomastigotes. In this model, the parasitemia increases 20 to 35 days post infection (dpi) (acute stage) and gradually wanes by day 40 to 45 dpi. There is a 50% mortality rate during the acute stage of infection. Surviving mice enter the chronic stage, and by 90 to 100 dpi there is a profound cardiomyopathy as determined by histopathology and cardiac imaging studies [18 (link), 19 (link)]. Additionally, we have detected the presence of parasites in the adipose tissue in both acutely and chronically infected mice [15 (link)]. Thirty and 90 dpi, sex and aged-matched control and infected CD-1 mice were sacrificed, and interscapular BAT and epididymal and mesenteric WAT were utilized in this study.
+ Open protocol
+ Expand
4

Monoclonal Antibody Inhibits Tumor Growth

Check if the same lab product or an alternative is used in the 5 most similar protocols

Example 7

C3H mice (Jackson Laboratory, ME) were inoculated with Ag104-MUC1 cell line, a mouse fibrosarcoma cell line stably transfected by MUC1 gene (9). 6-week old C3H mice were inoculated with 2 million tumor cells subcutaneously. 100 micrograms of 16A antibody were administered by intraperitoneal injection at the same day of tumor inoculation. 16A antibody drug was given at 100 microgram per mouse every 3 days. Control mouse IgG antibody (from Southern Biotech, AL) was used to treat the tumor-bearing mice in the control group. The perpendicular diameters of tumor were measured and the tumor area was used to represent tumor burden. In mice treated by 16A monoclonal antibody, the tumor growth is significantly inhibited.

+ Open protocol
+ Expand
5

Generation of Anti-Arp Antibodies in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Anti-Arp antibodies were raised in C3H mice (Jackson Laboratory, Bar Harbor, ME) by inoculating the mice with purified recombinant Arp as a water-in-oil emulsion formulation. A 0.5 mL volume of aqueous Arp antigen was emulsified in 0.5 mL of Titermax Gold (Sigma Aldrich, St. Louis, MO) adjuvant using a two-syringe, 3-way stopcock method. Each mouse was inoculated subcutaneously with 100 μl (36 μg protein) of the emulsion in four divided doses at four different sites. A booster dose of Arp antigen (total 12 μg) was administered in exactly in the same manner 28 days after the initial inoculation. Blood was collected (through cardiac puncture) after 2 weeks of booster dose and centrifuged at 6,000×g for 12 minutes at 4°C to separate serum from blood cellular components. Anti-Arp antibodies were isolated from serum using Melon Gel IgG Purification kit (Thermo Scientific).
+ Open protocol
+ Expand
6

Influenza Infection Model in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Female B10.S (H-2s), SJL and C3H mice, purchased from Jackson laboratories, were maintained in a specific pathogen-free facility at the University of Rochester Medical Center, according to institutional guidelines. For influenza infections, mice were anaesthetized with avertin (2,2,2-Tribromoethanol) via intraperitoneal injection and infected intranasally with 5 × 104 50% egg infectious dose (EID50) of influenza A/New Caledonia/20/1999 (H1N1) virus. All experimental groups were age-matched and used between 8–16 weeks of age.
+ Open protocol
+ Expand
7

Murine Mammary and Squamous Cell Tumor Models

Check if the same lab product or an alternative is used in the 5 most similar protocols
Murine mammary carcinoma cells, 4T1, and murine squamous cell carcinoma, SCCVII, cells were cultured at 37 °C and 5% CO2 in DMEM/F12 50-50 (Mediatech Inc., Manassas, VA) supplemented with 10% BCS. For tumor inoculation, cells at 80% confluence were harvested with 0.125% trypsin/EDTA. 4T1 or SCCVII cells were resuspended in serum free media at 2-4 × 105 cells/0.05 mL and implanted subcutaneously in the right rear limb of 2-4 month old female Balb/c mice (Charles River Laboratories) or three-month-old female C3H mice (Jackson Labs), respectively. Cell lines tested negative for mycoplasma.
+ Open protocol
+ Expand
8

Balb/c and C3H Mice in Animal Studies

Check if the same lab product or an alternative is used in the 5 most similar protocols
All animal studies were approved by the Institutional Animal Care and Use Committee (IACUC) of the University of Michigan (Protocol number PRO00006536 & 8556). Six- to 8-week-old female Balb/c mice and C3H mice were purchased from The Jackson Laboratory and Charles River Laboratories.
+ Open protocol
+ Expand
9

Generating Mutant Mice via ENU Mutagenesis

Check if the same lab product or an alternative is used in the 5 most similar protocols
ENU mutagenesis and breeding were performed as described on a pure C3HeB/FeJ (C3H) background (Hrabé de Angelis et al. 2000 (link); Sabrautzki et al. 2012 (link); Aigner et al. 2011 (link)). Briefly, C3H mice were originally purchased from the Jackson Laboratory (Bar Harbor, ME) and ENU (Serva Electrophoresis, Heidelberg, Germany) was applied in three weekly intervals by intraperitoneal injections of 90 mg/kg body weight to 10–12 wk old male mice (G0). G0 mice were mated with wild-type C3H females to produce F1 offspring. F1 males not showing any obvious phenotypic alterations were mated with wild-type C3H females to obtain the G2 generation. We either choose 6–8 female G2 mice for matings with their F1 father or performed intercross matings of G2 mice to produce at least 20 mice (G3 families). Phenotyping for dysmorphological alterations was performed according to a standardized protocol (Fuchs et al. 2000 (link)). A mutation was confirmed by showing a Mendelian distribution of expected homozygous mutant mice. The Scube3N294K/N294K mouse line was maintained on the C3H genetic background for more than 10 generations.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!